170 related articles for article (PubMed ID: 8926796)
1. [Screening with PSA (Prostate Specific Antigen) raises ethical questions].
Taube A
Lakartidningen; 1996 Sep; 93(39):3341. PubMed ID: 8926796
[No Abstract] [Full Text] [Related]
2. [Prostate cancer screening using prostate specific antigen (PSA) in Tokatsu Hospital--examination of lost-to-followup cases].
Shimizu N; Yamanaka H; Ichinose Y; Saitou Y
Hinyokika Kiyo; 1998 Mar; 44(3):155-8. PubMed ID: 9589875
[TBL] [Abstract][Full Text] [Related]
3. Prostate carcinoma: clarification through clinical insight and molecular diagnostics.
Meyers FJ; DeVere White RW
West J Med; 1998 Jun; 168(6):525. PubMed ID: 9655997
[No Abstract] [Full Text] [Related]
4. Update on screening for prostate cancer with prostate-specific antigen.
Schmid HP; Riesen W; Prikler L
Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160
[TBL] [Abstract][Full Text] [Related]
5. Is screening for prostate cancer the current gold standard?--"no".
Kramer BS; Gohagan JK; Prorok PC
Eur J Cancer; 1997 Mar; 33(3):348-53. PubMed ID: 9155515
[No Abstract] [Full Text] [Related]
6. Prostatic specific antigen in prostate cancer.
Wozniak-Petrofsky J
Urol Nurs; 1992 Sep; 12(3):104-5. PubMed ID: 1382317
[No Abstract] [Full Text] [Related]
7. Screening concerns.
Frelick R
Del Med J; 1996 Apr; 68(4):233-4. PubMed ID: 8635613
[No Abstract] [Full Text] [Related]
8. More on cancer screening.
Chodos J
Del Med J; 1996 Apr; 68(4):235-6. PubMed ID: 8635614
[No Abstract] [Full Text] [Related]
9. Detecting prostate cancer by intracellular macrophage prostate-specific antigen (PSA): a more specific and sensitive marker than conventional serum total PSA.
Herwig R; Mitteregger D; Djavan B; Kramer G; Margreiter M; Leers MP; Glodny B; Haider DG; Hörl WH; Marberger M
Eur J Clin Invest; 2008 Jun; 38(6):430-7. PubMed ID: 18489403
[TBL] [Abstract][Full Text] [Related]
10. PSA testing.
Frydenberg M
Aust Fam Physician; 2003 Jun; 32(6):396. PubMed ID: 12833760
[No Abstract] [Full Text] [Related]
11. PSA: prostate-specific antigen, persisting scientific ambiguities.
Harv Mens Health Watch; 2009 Jul; 13(12):1-6. PubMed ID: 19718841
[No Abstract] [Full Text] [Related]
12. Mass screening for prostate cancer. The Swedish Council on Technology Assessment in Health Care.
Int J Cancer Suppl; 1996; 9():1-72. PubMed ID: 8982323
[No Abstract] [Full Text] [Related]
13. Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry.
Stattin P; Johansson R; Damber JE; Hellström M; Hugosson J; Lundgren R; Varenhorst E; Johansson JE
Scand J Urol Nephrol; 2003; 37(6):461-5. PubMed ID: 14675917
[TBL] [Abstract][Full Text] [Related]
14. Is an improved PSA screening test in sight?
Savage L
J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
[No Abstract] [Full Text] [Related]
15. [Prostatic specific antigen in practice in 1997].
Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC
Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634
[TBL] [Abstract][Full Text] [Related]
16. Patient education. PSA: pros and cons.
Gattellari M; Ward JE
Aust Fam Physician; 2003 Jun; 32(6):429-30. PubMed ID: 12833769
[No Abstract] [Full Text] [Related]
17. Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
Hamilton RJ; Platz EA; Freedland SJ
J Natl Cancer Inst; 2009 Apr; 101(8):611-2. PubMed ID: 19351913
[No Abstract] [Full Text] [Related]
18. Is screening for prostate cancer the current gold standard?--"yes".
Lange PH
Eur J Cancer; 1997 Mar; 33(3):354-6. PubMed ID: 9155516
[No Abstract] [Full Text] [Related]
19. PSA screening: the bottom line.
Elhilali MM
CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466
[No Abstract] [Full Text] [Related]
20. [Advancements in PSA-based screening for prostate cancer].
Ito K
Rinsho Byori; 2004 Jul; 52(7):611-7. PubMed ID: 15344561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]